EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repair

Journal of Bone and Mineral Research

Volumn 28, Issue 4, 2013, Pages 926-935

  Arthur, Agnieszka ^a   Panagopoulos, Romana A ^a   Cooper, Lachlan ^a   Menicanin, Danijela ^a   Parkinson, Ian H ^b   Codrington, John D ^b,c   Vandyke, Kate ^c   Zannettino, Andrew C W ^c   Koblar, Simon A ^a   Sims, Natalie A ^d   Matsuo, Koichi ^e   Gronthos, Stan ^a,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Bone and Joint Research Laboratory   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e KEIO UNIVERSITY   (Japan)

Author keywords

bone repair; endochondral ossification; EPHB4; mesenchymal stem cells; osteoblasts

Indexed keywords

COLLAGEN TYPE 1; EPHRIN RECEPTOR B4; MINERAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MASS; BONE MINERALIZATION; BONE REMODELING; BONE STRENGTH; CALLUS; CELL MATURATION; CHONDROGENESIS; CLONOGENESIS; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; EPHB4 GENE; FEMALE; FEMUR FRACTURE; GENE; GENE OVEREXPRESSION; IN VITRO STUDY; MALE; MESENCHYMAL STROMA CELL; MINERALIZATION; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSTEOCLAST; OSTEOSYNTHESIS; PROMOTER REGION; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; BIOMECHANICS; CELL COUNT; FRACTURE; FRACTURE HEALING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY; STEM CELL;

ANIMALS; BIOMECHANICAL PHENOMENA; BONE REMODELING; BONY CALLUS; CELL COUNT; COLLAGEN TYPE I; FEMALE; FRACTURE HEALING; FRACTURES, BONE; GENE EXPRESSION REGULATION; MALE; MICE, TRANSGENIC; MINERALS; OSTEOGENESIS; RECEPTOR, EPHB4; STEM CELLS; X-RAY MICROTOMOGRAPHY;

EID: 84875324671     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1821     Document Type: Article

References (26)

1. Manigrasso MB, O'Connor JP., Characterization of a closed femur fracture model in mice. J Orthop Trauma. 2004; 18 (10): 687-95.
2. Einhorn TA., The cell and molecular biology of fracture healing. Clin Orthop Relat Res. 1998; 355 (Suppl): S7-21.
3. Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T, Suda T, Matsuo K., Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab. 2006; 4 (2): 111-21.
4. Pasquale EB., Eph-ephrin bidirectional signaling in physiology and disease. Cell. 2008; 133 (1): 38-52.
5. Mao Y, Huang X, Zhao J, Gu Z., Preliminary identification of potential PDZ-domain proteins downstream of ephrin B2 during osteoclast differentiation of RAW264.7 cells. Int J Mol Med. 2011; 27 (5): 669-77.
6. Arthur A, Zannettino A, Panagopoulos R, Koblar SA, Sims NA, Stylianou C, Matsuo K, Gronthos S., EphB/ephrin-B interactions mediate human MSC attachment, migration and osteochondral differentiation. Bone. 2011; 48 (3): 533-42.
7. Allan EH, Hausler KD, Wei T, Gooi JH, Quinn JM, Crimeen-Irwin B, Pompolo S, Sims NA, Gillespie MT, Onyia JE, Martin TJ., EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts. J Bone Miner Res. 2008; 23 (8): 1170-81.
8. Wang HU, Chen ZF, Anderson DJ., Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell. 1998; 93 (5): 741-53.
9. Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, Risau W, Klein R., Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 1999; 13 (3): 295-306.
10. Gerety SS, Wang HU, Chen ZF, Anderson DJ., Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell. 1999; 4 (3): 403-14.
11. Duvall CL, Taylor WR, Weiss D, Wojtowicz AM, Guldberg RE., Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice. J Bone Miner Res. 2007; 22 (2): 286-97.
12. Silva MJ, Brodt MD, Ettner SL., Long bones from the senescence accelerated mouse SAMP6 have increased size but reduced whole-bone strength and resistance to fracture. J Bone Miner Res. 2002; 17 (9): 1597-603.
13. Schriefer JL, Robling AG, Warden SJ, Fournier AJ, Mason JJ, Turner CH., A comparison of mechanical properties derived from multiple skeletal sites in mice. J Biomech. 2005; 38 (3): 467-75.
14. Vandyke K, Dewar AL, Diamond P, Fitter S, Schultz CG, Sims NA, Zannettino AC., The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo. J Bone Miner Res. 2010; 25 (8): 1759-70.
15. Fitter S, Dewar AL, Kostakis P, To LB, Hughes TP, Roberts MM, Lynch K, Vernon-Roberts B, Zannettino AC., Long-term imatinib therapy promotes bone formation in CML patients. Blood. 2008; 111 (5): 2538-47.
16. Vandyke K, Dewar AL, Fitter S, Menicanin D, To LB, Hughes TP, Zannettino AC., Imatinib mesylate causes growth plate closure in vivo. Leukemia. 2009; 23 (11): 2155-9.
17. Fitter S, Vandyke K, Schultz CG, White D, Hughes TP, Zannettino AC., Plasma adiponectin levels are markedly elevated in imatinib-treated chronic myeloid leukemia (CML) patients: a mechanism for improved insulin sensitivity in type 2 diabetic CML patients?. J Clin Endocrinol Metab. 2010; 95 (8): 3763-7.
18. Martin TJ, Allan EH, Ho PW, Gooi JH, Quinn JM, Gillespie MT, Krasnoperov V, Sims NA., Communication between EphrinB2 and EphB4 within the osteoblast lineage. Adv Exp Med Biol. 2010; 658: 51-60.
19. Arthur A, Koblar S, Shi S, Gronthos S., Eph/ephrinB mediate dental pulp stem cell mobilization and function. J Dent Res. 2009; 88 (9): 829-34.
20. Das A, Shergill U, Thakur L, Sinha S, Urrutia R, Mukhopadhyay D, Shah VH., Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment. Am J Physiol Gastrointest Liver Physiol. 2010; 298 (6): G908-15.
21. Pennisi A, Ling W, Li X, Khan S, Shaughnessy JD Jr, Barlogie B, Yaccoby S., The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth. Blood. 2009; 114 (9): 1803-12.
22. Kwan Tat S, Pelletier JP, Amiable N, Boileau C, Lajeunesse D, Duval N, Martel-Pelletier J., Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts. Arthritis Rheum. 2008; 58 (12): 3820-30.
23. Kwan Tat S, Pelletier JP, Amiable N, Boileau C, Lavigne M, Martel-Pelletier J., Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes. Arthritis Res Ther. 2009; 11 (4): R119.
24. Diercke K, Kohl A, Lux CJ, Erber R., Strain-dependent up-regulation of ephrin-B2 protein in periodontal ligament fibroblasts contributes to osteogenesis during tooth movement. J Biol Chem. 2011; 286 (43): 37651-4.
25. Pasquale EB., Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer. 2010; 10 (3): 165-80.
26. Noberini R, Mitra S, Salvucci O, Valencia F, Duggineni S, Prigozhina N, Wei K, Tosato G, Huang Z, Pasquale EB., PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity. PLoS One. 2011; 6 (12): e28611.